[CytoReason in Jewish News] Israeli start-up secured a deal with Pfizer just a year after launch
David Harel, founder of CytoReason, tells the tale of every entrepreneur’s dream Read...
Read MoreNov 22, 2022 | News Center
David Harel, founder of CytoReason, tells the tale of every entrepreneur’s dream Read...
Read MoreNov 22, 2022 | News Center
SYDNEY, Nov. 22, 2022 – Q-CTRL, a global leader in quantum control infrastructure software, and Classiq, the leader in quantum algorithm development software, today announced a partnership to provide an end-to-end platform for designing, executing, and analyzing quantum algorithms. Read more...
Read MoreNov 22, 2022 | News Center
SAN JOSE, Calif., Nov. 22, 2022 /PRNewswire/ — Malwarebytes, a global leader in real-time cyber protection, today announced a new partnership with Stellar Cyber, an industry-leading Open XDR platform that delivers comprehensive, unified security without complexity. The partnership helps resource-constrained teams produce consistent security outcomes across all environments; on-premises, cloud and anything in between. Read more...
Read MoreNov 22, 2022 | News Center
ASHBURN, Va., Nov. 22, 2022 /PRNewswire/ — Anodot, the augmented FinOps company, today announced the integration of its patented machine learning anomaly detection technology into the company’s cloud cost management solution. Anodot’s autonomous FinOps solution gives organizations greater visibility, control and insight into cloud costs. The company’s AI and ML-powered solution allows for automated savings recommendations and accurate forecasts that enable customers to minimize cloud waste and reduce overall cloud spend. Read more...
Read MoreNov 22, 2022 | News Center
A new Israeli app can sound the alarm before the onset of congestive heart failure — just by analyzing the sound of a user’s voice. A study with recovered patients found that the app predicted some 82 percent of relapses before they happened. Read...
Read More